Page 92 - Remedial Andrology
P. 92

of the disease [994, 995]. Palpable plaques have been reported as an initial symptom in 39% of the patients
                        and mostly situated dorsally [50, 997].

                        In addition to functional effects on sexual intercourse, men may also suffer from significant psychological
                        distress. Validated mental health questionnaires have shown that 48% of men with PD have moderate or
                        severe depression, sufficient to warrant medical evaluation [998].

                        8.2.1.5   Summary of evidence on epidemiology/aetiology/pathophysiology of Peyronie’s disease


                        Summary of evidence                                                             LE
                        Peyronie’s disease (PD) is a connective tissue disorder, characterised by the formation of a fibrotic   2b
                        lesion or plaque in the tunica albuginea, which may lead to penile deformity.
                        The contribution of associated co-morbidity or risk factors (e.g., diabetes, hypertension, lipid   3
                        abnormalities and Dupuytren’s contracture) to the pathophysiology of PD is still unclear.
                        Two phases of the disease can be distinguished. The first phase is the active inflammatory phase   2b
                        (acute phase - painful erections, nodule/plaque), and the second phase is the fibrotic/calcifying phase
                        (chronic or stable phase) with formation of hard palpable plaques (disease stabilisation).
                        Spontaneous resolution is uncommon (3-13%) and most patients experience disease progression   2a
                        (21-48%) or stabilisation (36-67%). Pain is usually present during the early stages of the disease, but
                        tends to resolve with time in 90% of men within 12 months of onset.


                        8.2.2   Diagnostic evaluation
                        The aim of the initial evaluation is to obtain information on the presenting symptoms and their duration (e.g.,
                        pain on erection, palpable nodules, deformity, length and girth and erectile function). It is important to obtain
                        information on the distress caused by the symptoms and the potential risk factors for ED and PD. A disease-
                        specific questionnaire (Peyronie’s disease questionnaire [PDQ]) has been developed for use in clinical practice
                        and  trials.  Peyronie’s  disease  questionnaire  measures  three  domains, including  psychological  and  physical
                        symptoms, penile pain and symptom bother [999].

                        Clinicians should take a focused history to distinguish between active and stable disease, as this will influence
                        medical treatment or the timing of surgery. Patients who are still likely to have active disease are those with
                        a shorter symptom duration, pain on erection, or a recent change in penile deformity. Resolution of pain and
                        stability of the curvature for at least 3 months are well-accepted criteria of disease stabilisation and patients’
                        referral for specific medical therapy [1000, 1001] or surgical intervention when indicated [1002].

                        The examination should start with a focused genital assessment that is extended to the hands and feet
                        for detecting possible Dupuytren’s contracture or Ledderhosen scarring of the plantar fascia  [995]. Penile
                        examination is performed to assess the presence of a palpable nodule or plaque. There is no correlation
                        between plaque size and degree of curvature [1003]. Measurement of the stretched or erect penile length is
                        important because it may have an impact on the subsequent treatment decisions and potential medico-legal
                        implications [1004-1006].

                        An objective assessment of penile curvature with an erection is mandatory. According to current literature, this
                        can be obtained by several approaches, including home (self) photography of a natural erection (preferably),
                        using a vacuum-assisted erection test or an ICI using vasoactive agents. However, it has been suggested that
                        the ICI method is superior, as it is able to induce an erection similar to or better than that which the patient
                        would experience when sexually aroused [1007-1009]. Computed tomography and MRI have a limited role in
                        the diagnosis of the curvature and are not recommended on a routine basis. Erectile function can be assessed
                        using validated instruments such as the IIEF although this has not been validated in PD patients [1010]. Erectile
                        dysfunction is common in patients with PD (30-70.6%) [1011, 1012]. It is mainly an arterial or cavernosal (veno-
                        occlusive) dysfunction in origin [985, 1003, 1013]. The presence of ED and psychological factors may also have
                        a profound impact on the treatment strategy [1012].

                        Ultrasound measurement of plaque size is inaccurate but it could be helpful to assess the presence of the
                        plaque and its calcification and location [1014, 1015]. Doppler US may be used for the assessment of penile
                        haemodynamics and ED aetiology [1012].








                        SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021                                        91
   87   88   89   90   91   92   93   94   95   96   97